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PROSTATIC CANCER PRESENTING 
MONOCLONAL GAMMOPATHY: 
REPORT OF TWO CASES 
Masakazu Tsutsumi, Toru Hara and Ritsu Fukasawa 
From the Department of Urology, Kameda General Hospital 
Kenkichi Koiso 
From the Department of Urology, Tsukuba University 
Two cases of prostatic cancer accompanied by monoclonal gammopathy of undetermined signif-
icance (MGUS) are reported. Both cases presented IgG-,l type hyperimmunoglobulinemia and 
Bence Jones protein (BJP) in the urine. A characteristic of both cases was significant multiple 
bone metastasis, and one case also demonstrated a severe immunological disorder. During the 
treatment, one patient recovered from MGUS. We recommend that elderly male patients mani-
festing MGUS be examined for prostatic cancer. 
(Acta U roI. Jpn. 39: 569-572, 1993) 
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INTRODUCTION 
Monoclonal gammopathy of undeter-
mined significance (MGUS) is a disorder 
due to the proliferation of a single clone 
of the plasma cells. The condition report-
edly may be caused by an autoimmune 
disease, chronic infection, a state of 
immunodeficiency, liver disease and mali-
gnancy!). MG US is reported to be present 
in 0.9% of the normal adult population, 
with this incidence increasing to 3% among 
individuals more than 70 years 0Id 2,3l. 
Three (5%) of 66 consecutive patients 
exhibiting BJP proteinuria were classified as 
having MGUS4l. The concentration of the 
monoclonal protein in MG US is almost 
less than 3 p.g per 100 ml, and the immu-
noglobulins other than this usually are not 
suppressed4- 6l . Although the pathogenetic 
mechanism of MGUS is not clear, cancer 
or chronic inflammation stimulates proli-
feration of a single clone of a plasma cell 
and leads to MGUSD. Aging and cancer 
have also been suggested to cause immune 
disorders which may lead to MGUS. He-
rein, we report two cases of prostatic can-
cer presenting MGUS. It was characteris-
tic that one case showed severe immuno-
supression. 
CASE REPORT 
Case 1. An 81-year-old male presented 
himself with a high fever. The laboratory 
data revealed high levels of lactate dehy-
drogenase (LDH; 699U /1) and alkaline 
phosphatase (Alp; 1,015 mU/ml) in addi-
tion to hyperimmunoglobulinemia (Fig. 
lA). Immunoelectrophoresis of serum re-
vealed an M band suggesting IgG-A type 






Fig. I. Serum protein fractions in case 1 (A,B) 
and case 2 (C). Arrow indicates mono-
clonal band of immunoglobulin. Case 1 
patient showed monoclonal gammopathy 
at admission (A), but had recovered 
after 4 months of treatment (B). 
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JP) was identified in his urine. The IgG, 
IgA and IgM contents of serum were 3,30S 
292 and 126 mg/dl, respectively. A bone 
marrow biopsy specimen revealed reactive 
plasmacytosis (bone marrow plasma cells; 
S.S%). A general bone survey indicated a 
focal osteoblastic region, but failed to 
reveal either a region of bone lysis or 
generalized osteoporosis. Bone scintigraphy 
revealed multiple hot spots. These 
findings were not characteristic of multiple 
myeloma. 
A stone-hard prostate and the high level 
of serum prostate acid phosphatase (PAP; 
21S ng/ml) indicated prostatic cancer with 
multiple bone metastasis. The T4/TS lym-
phocyte ratio was a low 0.35 (normal LIS 
to 2.0S), idicating a severe immunosup-
pression. The patient underwent castration 
and was administered transorally 300 mg 
of diethylstilbestrol phosphate (DES) fol-
lowing trans rectal biopsy of the prostate. 
Histological examination demonstrated 
moderately differentiated adenocarcinoma 
in the prostate (Fig. 2A). The patient's 
body temperature rose during treatment, 
and was lowered not by antibiotics but 
by immunoglobulin. Improvement of the 
hyperimmunoglobulinemia was registered 
after four months of treatment (Fig. I B). 
However, the patient died of prostration 
and cachexia. 
Case 2. An SS-year-old male presented 
himself with anorexia and nocturnal urina-
ry frequency. Laboratory studies revealed 
elevations in serum BUN (47 mg/dl), Cr 
(2.6mg/dl), LDH (506U/l), Alp (615mU 
/1), and PAP (15 ng/dl), and hyperimmuno-
globulinemia (Fig. I C). The serum 
immunoelectrophoresis indicated the 
presence of an IgG-A type M-protein, and 
BJP was found in the urine. 
Transrectal biopsy of the prostate indi-
cated a moderately differentiated adeno-
carcinoma (Fig. 2B). However, repeated 
bone marrow biopsy failed to indicate the 
presence of plasmacytoma. Bone scintig-
raphy demonstrated a multiple radio-
isotope uptake, suggesting multiple metasta-
sis of the prostatic cancer. The patient 
was subjected to castration and subse-
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Fig. 2. The histological findings of prostate in 
case I (A) and case 2 (B). H & E 
staining (x 100). 
DES. BJP proteinuria persisted and dys-
pnea accompanied by pleural effusion oc-
curred IS months postoperatively. Aspira-
tion of the pleural fluid and pleural biopsy 
confirmed the presence of adenocarcinoma, 
indicating the pleural metastasis of the 
prostatic cancer. The patient died from 
respiratory failure two years after treat-
mement. 
Post-mortem examination revealed adeno-
carcinoma infiltration of bone marrow 
tissue, but not plasma cells. There was 
cancer cell infiltration of the pleural wall, 
which mediated the massive pleural effu-
sion. An adenocarcinoma was also iden-
tified in the prostate. The diagnosis essen-
tially was MG US accompanying prostatic 
cancer which metastasized to the bone and 
pleura. 
DISCUSSION 
MGUS refers to a condition In which 
monoclonal protein is present but not 
Tsutsumi, et al.: Prostatic cancer. Monoclonal gammopathy 571 
associated with myeloma, amyloidosis, 
macrogloburinemia or a malignant Iympho-
proliferative process. It is well known to 
increase in incidence with age7). A differ-
ence in incidence by race also has been 
reporded. Blacks had a two times higher 
incidence of MG US than whites8). Malig-
nancy in MG US ranges from 7 to 14.8 per-
cent5 9), and the prevalence of the different 
types of tumors associated with MGUS is 
variable7) Few reports discuss the progno-
sis of the malignancy showing MG US, but 
MGUS must be followed up indefinitely, 
because such reporded long-term foil ow-
ups have indicated the development of 
myeloma in 22% of the cases, and of mac-
rogloburinemia in 3 % of the cases10) 
Four cases of prostatic cancer associated 
with MGUS have been described in previ-
ous reports79 ill. However, detailed ex-
planations were not provided. Prostatic 
cancer is the most common cancer which 
metastasizes to bone. It is speculated that 
either direct or indirect stimulation of 
plasma cells by the metastatic bone tumor 
leads to MGUS. 
An immune disorder also has been re-
ported to cause MG USll. In case I, de-
crease in the T4/T8 lymphocyte ratio indi-
cates severe immunosuppression. In this 
case, the fever lowered by the administra-
tion of immunoglobulin was presumed to 
have been caused by interleukine I medi-
ated from active macrophage by excess anti-
gen stimulation of a cancer, because the 
administration of immunoglobulin may 
block macrophage complement receptors. 
Prostatic cancer belongs to the high risk 
group demonstrating MGUS, because it 
tends to metastasize to the bone and 
invade the bone marrow. In conclusion, we 
recommend an examination for prostatic 
cancer in elderly male patients with MG-
US. 
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和文抄録
単 クロー ン性形質細胞増多症を示 した前立腺癌 の2例
亀田総合病院泌尿器科(部長=原 徹)
堤 雅 一*,原 徹,深 沢 立
筑波大学臨床医学系泌尿器科(主任=小磯謙吉教授)
小 磯 謙 吉
われわれは単クローン性形質細胞増多症(MGUS)
を示 した前立腺癌を2例 経験 した.2例 ともIgG一λ




改善が認められた.高 齢の男性 でMGUSを 示 した
症例は,前 立腺癌の可能性を一度考える必要があると
思われた.
(泌尿紀要39=569-572,1993)
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